Target intelligence / Profile preview

Transmembrane protein 209 (TMEM209)

Target
TMEM209
Molecular classification
Other, Transmembrane protein, Predicted nucleoporin
01

Overview

Transmembrane protein 209 (TMEM209) is a protein located primarily at the nuclear envelope and potentially the Golgi apparatus, with a structural role as an integral membrane protein[2][3][5]. TMEM209 contains two predicted transmembrane domains and has been implicated as a nucleoporin or nuclear envelope protein interacting with core nuclear pore complex (NPC) components, such as NUP205, POM121, and Nup210[2][3]. It is thought to contribute to nuclear integrity, chromatin organization, and regulation of gene expression[2]. Experimental depletion of TMEM209 results in alterations to nuclear envelope morphology and impairs cell cycle progression, particularly during the S phase[2]. Increased expression and interaction with NUP205 have been associated with lung cancer cell proliferation, suggesting a possible role in tumorigenesis[9][3]. TMEM209 is poorly characterized, with no known drug interactions or established biomarkers, and is not currently recognized as a direct therapeutic target.

Other names
FLJ14803NET31testicular tissue protein Li 202tmem209fc20f10fe36f06im:6909884si:ch211-240j22.1wu:fc20f10wu:fe36f06
02

Biological functions

Nuclear envelope organizationChromatin organizationNuclear transportRegulation of gene expressionCell cycle
03

Disease associations

Cancer (including lung cancer)Emery-Dreifuss muscular dystrophy (associated condition)

Beyond the preview

Go deeper on Transmembrane protein 209 (TMEM209).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 209 (TMEM209).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call